DFTX Q4 2017 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

Q4 2017 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$3,513

Operating Income

-$168,477

Net Income

-$165,383

EPS (Diluted)

$-0.53

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$157,489

Free Cash Flow

-$239,310

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4M

Total Liabilities

$68,843

Stockholders' Equity

$4M

Cash & Equivalents

$41,913

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3,513	$0	—
Operating Income	-$168,477	-$314,199	+46.4%
Net Income	-$165,383	-$318,489	+48.1%